Biblio
Altered function of the glutamate-aspartate transporter GLAST, a potential therapeutic target in glioblastoma. Int J Cancer. 2018.
Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature. 2022.
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas. Cell Rep. 2023;42(8):112816.
DNA Damage in Mammalian Neural Stem Cells Leads to Astrocytic Differentiation Mediated by BMP2 Signaling through JAK-STAT. Stem Cell Reports. 2013;1(2):123-38.
. ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma. Cell Rep. 2021;36(4):109455.
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration. Oncotarget. 2012;3(10):1146-57.
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors. J Neurooncol. 2023.
Human glioblastoma stem-like cells accumulate protoporphyrin IX when subjected to exogenous 5-aminolaevulinic acid, rendering them sensitive to photodynamic treatment. J Photochem Photobiol B. 2016;163:203-210.
. The landscape of the mesenchymal signature in brain tumours. Brain. 2019;142(4):847-866.
. Perspectives for immunotherapy in glioblastoma treatment. Curr Opin Oncol. 2014.
.